Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6295-6300

  Tian, Shu Bo ^a   Yu, Jian Chun ^a   Kang, Wei Ming ^a   Ma, Zhi Qiang ^a   Ye, Xin ^a   Cao, Zhan Jiang ^a   Yan, Chao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

CA 242; CA 50; Carcinoembryonic antigen; Diagnosis; Gastric cancer; Prognosis

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CA-50 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AGED; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR INVASION;

AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BIOMARKERS, TUMOR; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84906251651     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6295     Document Type: Article

References (33)

1. Aizawa M, Gotohda N, Takahashi S, et al (2011). Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg, 35, 2717-22.
2. Aloe S, D'Alessandro R, Spila A, et al (2003). Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer. Int J Biol Markers. 18, 21-7.
3. A.M. Attallah, N.A. Al-Ghawalby, A.A.F. Abdel Aziz, et al (2006). Clinical value of serum CEA, CA 19-9, CA 242 and AFP in diagnosis of gastrointestinal tract cancers. Int J Cancer Res, 2, 50-6.
4. Bagaria B, Sood S, Sharma R, Lalwani S (2013). Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med, 10, 148-57.
5. Carpelan-Holmstrom M, Haglund C, Lundin J, et al (1996). Preoperative serum levels of CA 242 and CEA predict outcome in colorectal cancer. Eur J Cancer, 32, 1156-61.
6. Choi SR, Jang JS, Lee JH, et al (2006). Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy. Dig Dis Sci, 51, 2081-6.
7. Duraker N, Celik AN (2001). The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol, 76, 266-71.
8. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
9. Gonzalez A, Vizoso F, Allende MT, et al (1996). Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma. Int J Biol Markers, 11, 165-71.
10. Gwak HK, Lee JH, Park SG (2014). Preliminary evaluation of clinical utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in stomach cancer. Asian Pac J Cancer Prev, 15, 4933-8.
11. He CZ, Zhang KH, Li Q, et al (2013). Combined use of AFP, CEA, CA125 and CA 19-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol, 14, 13-87.
12. Hwang GI, Yoo CH, Sohn BH, et al (2004). Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma. Cancer Res Treat, 36, 178-81.
13. Johansson C, Nilsson O, Lindholm L (1991). Comparison of serological expression of different epitopes on the CA50-carrying antigen CanAg. Int J Cancer, 48, 757-63.
14. Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol, 104, 504-10.
15. Kim DY, Kim HR, Shim JH, et al (2000). Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol, 74, 185-92.
16. Kodera Y, Yamamura Y, Torii A, et al (1996). The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Am J Gastroenterol, 91, 49-53.
17. Kuusela P, Haglund C, Roberts PJ, Jalanko H (1987). Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer, 55, 673-76.
18. Li F, Li S, Wei L, et al (2013). The correlation between preoperative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers, 18, 632-37.
19. Marrelli D, Pinto E, De Stefano A, et al (2001). Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg, 181, 16-9.
20. Marrelli D, Roviello F, De Stefano A, et al (1999). Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology, 57, 55-62.
21. Mihmanli M, Dilege E, Demir U, et al (2004). The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology, 51, 1544-7.
22. Mittal A, Gupta SP, Jha DK, et al (2013). Impact of various tumor markers in prognosis of gastric cancer. A hospital based study from tertiary care hospital of Kathmandu valley. Asian Pac J Cancer Prev, 14, 1965-7.
23. Nilsson O, Johansson C, Glimelius B, et al (1992). Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer, 65, 215-21.
24. Ni XG, Bai XF, Mao YL, et al (2005). The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol, 31, 164-9.
25. Shimada H, Takiguchi N, Kainuma O, et al (2010). High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 13, 170-6.
26. Sisik A, Kaya M, Bas G, et al (2013). CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev, 14, 4289-94.
27. Tachibana M, Takemoto Y, Nakashima Y, et al (1998). Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg, 187, 64-8.
28. Ucar E, Semerci E, Ustun H, et al (2008). Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther, 25, 1075-84.
29. Xiao J, He X, Wang Z, et al (2014). Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer. Tumour Biol, 35, 1331-4.
30. Yang XQ, Chen C, Peng CW, et al (2012). Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Med Oncol, 29, 1030-6.
31. Ychou M, Duffour J, Kramar A, et al (2000). Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers, 16, 105-10.
32. Yu H, Liu X (2013). The diagnostic value of CEA combined with CA199, CA724, CA 242 for gastric cancer. Medical Laboratory Science Clinics, 4, 15-6.
33. Zhu YB, Ge SH, Zhang LH, et al (2012). Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 15, 161-4.